A flux of the reds: Evolution of active management of the third stage of labour

Department of Health. Why Mothers Die: Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-96. London: Stationery Office, 1998

Nunn JF. Ancient Egyptian Medicine. London: British Museum Press, 1996: 193–5

Gunther RT. The Greek Herbal of Dioscorides, book 2. London: Hafner Publishing 1968: 203

Gerard J. The Herbal or General History of Plants (complete 1633 edition as revised and enlarged by Thomas Johnson). New York: Dover Publications, 1970: 1040

Smellie W. A Treatise on the Theory and Practice of Midwifery. London: D Wilson, 1752: 402–4

Moir JC. The history and present day use of ergot. Can Med Assoc J 1955; 72: 727–34

Paulitsky F. Pulvis ad partum aus dem Mutterkorn. Neues Mag für Arzte 1787; 9: 44

Stearns J. Account of the pulvis parturiens, a remedy for quickening childbirth. Med Repository NY 1808; 11: 308–9

Stearns J. Observations on the secale cornutum or ergot, with directions for its use in parturition. Med Rec 1822; 5: 90

Prescott O. A Dissertation on the Natural History and Medical Effects of the Secale Cornutum, or Ergot. Andover: Flagg & Gould, 1813: 14

Hosack D. Observations on ergot. In: Essays on Various Subjects of Medical Science. New York: 1824: 295–301

Tanret C. Sur la presence d'une nouvelle alkaloide, l'ergotinine, dans seigle ergoté. CR Acad Sci 1875; 81: 896–7

Barger G , Carr FH , Dale HH. An active alkaloid from ergot. BMJ 1906; ii:1792

Stoll A. Zur Kenntins der Mutterkorn alkaloide. Verhand der Schweiz Naturf Ges 1920; 6: 190

Hart DB. Guide to Midwifery. London: Heinemann, 1912: 220

Schatz F. Beitrage zur physiologischen Geburtskunde. Arch Gynakol 1872; 3: 58–9

Rübsamen W. Klinisch-experimentelle Untersuchungen über die Wirksamkeit der Wehenmittel in der Nachgeburtsperiode. Munch Med Wschr 1913; 12: 627–30

Bourne A , Burn JH. The dosage and action of pituitary extract and ergot alkaloids on the uterus in labour, with a note on the action of adrenalin. J Obstet Gynaecol Br Emp 1927; 34: 249–68

Moir JC. The obstetrician bids, and the uterus contracts. BMJ 1964; i: 1025–9

Moir JC. The action of ergot preparations on the puerperal uterus. BMJ 1932; i: 1119–22

Dudley HW , Moir C. The substance responsible for the traditional clinical effect of ergot. BMJ 1935; i: 520–3

Davis ME , Adher FL , Rogers G , Kharasch MS , Legault RR. A new active principle in ergot and its effects on uterine motility. Am J Obstet Gynecol 1935; 29: 155–67

Thompson MR. The active constituents of ergot. A pharmacological and chemical study. J Am Pharm Soc 1935; 24: 185–96

Stoll A , Burckhardt E. L'ergobasine, nouvel alkaloide de l'ergot de seigle, solubile dans l'eau. Bull Sci Pharm 1935; 42: 257–66

Dudley HW. Ergometrine. Proc R Soc Lond 1935; 118: 478–84

Flew JDS. Discussion on the management of the normal third stage of labour and of haemorrhage therein. Proc R Soc Med 1947; 40: 370–1

Davis ME. Postpartum hemorrhage. Am J Surg 1940; 48: 154–63

Davis ME , Boynton MW. The use of ergonovine in the placental stage of labor. Am J Obstet Gynecol 1942; 43: 775–90

Shaw DAF. Oxytocic drugs in the third stage of labour. J Obstet Gynaecol Br Emp 1949; 56: 833–7

Daley D. The use of intramuscular ergometrine at the end of the second stage of normal labour. J Obstet Gynaecol Br Emp 1951; 58: 388–97

Du Vigneaud V , Ressler C , Swan JM , Roberts CW , Katsoyannis PG , Gordon S. The synthesis of an octapeptide with the hormonal activity of oxytocin. J Am Chem Soc 1953; 75: 4879–80

Prendiville WJ , Harding JE , Elbourne DR , Stirrat GM. The Bristol third stage trial; active versus physiological management of third stage of labour. BMJ 1988; 297: 1295–300

Prendiville WJ , Elbourne DR , Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95: 3–16

Elbourne DR , Prendiville WJ , Chalmers I. Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95: 17–30

Soriano D , Dulitzki M , Schiff E , Barkai G , Mashiach S , Seidman DS. A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1996; 103: 1068–73

Nordström L , Fogelstam K , Fridman G , Larsson A , Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997; 104: 781–6

Bergstrom S , Ryhag ER , Samuelson B , Sjovall J. The structure of prostaglandin E, F₁ and F₂. Acta Chem Scan 1962; 16: 501–2

Annathasubramanim L , Kuntal R , Sivariman R , Raghaven KS. Management of intractable postpartum haemorrhage secondary to uterine atony with intramuscular 15-methyl PGF₂α. Acta Obstet Gynecol Scand 1988; 145(suppl):17–19

El-Refaey H , O'Brien P , Morafa W , Walder J , Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1997; 104: 336–9